Spanish scientists demonstrate efficacy of new drug against glioblastoma, Barcelona, ES - 02 Aug 2022
Researchers at the Vall d'Hebron Institute of Oncology (VHIO) have demonstrated the preclinical efficacy of a new immunological drug based on an antibody that can regress glioblastoma, the most common and aggressive brain tumour. The research, led by the oncologist and director of Translational Research at VHIO, Joan Seoane, has achieved "extraordinary results" in preclinical models of this type of tumour. FOOTAGE OF THE VALL D'HEBRON INSTITUTE OF ONCOLOGY (VHIO) IN BARCELONA.